These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8876851)

  • 1. Evaluation of symptom distress in a bone marrow transplant outpatient environment.
    Lawrence CC; Gilbert CJ; Peters WP
    Ann Pharmacother; 1996 Sep; 30(9):941-5. PubMed ID: 8876851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
    Winer EP; Lindley C; Hardee M; Sawyer WT; Brunatti C; Borstelmann NA; Peters W
    Psychooncology; 1999; 8(2):167-76. PubMed ID: 10335560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
    Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
    Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.
    Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Dix S; Cord M; Howard S; Coon J; Belt R; Geller R
    Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
    Laughlin MJ; McGaughey DS; Crews JR; Chao NJ; Rizzieri D; Ross M; Gockerman J; Cirrincione C; Berry D; Mills L; Defusco P; LeGrand S; Peters WP; Vredenburgh JJ
    J Clin Oncol; 1998 Mar; 16(3):1008-12. PubMed ID: 9508184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population.
    Lindley CM; Bernard S; Fields SM
    J Clin Oncol; 1989 Aug; 7(8):1142-9. PubMed ID: 2787840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem autotransplantation for the treatment of metastatic breast cancer.
    Broun ER; Sridhara R; Sledge GW; Loesch D; Kneebone PH; Hanna M; Hromas R; Cornetta K; Einhorn LH
    J Clin Oncol; 1995 Aug; 13(8):2050-5. PubMed ID: 7636548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychologic and neuropsychologic impact of autologous bone marrow transplantation.
    Ahles TA; Tope DM; Furstenberg C; Hann D; Mills L
    J Clin Oncol; 1996 May; 14(5):1457-62. PubMed ID: 8622059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
    Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
    Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.
    Llombart-Cussac A; Ramos M; Dalmau E; García-Saenz JA; González-Farré X; Murillo L; Calvo L; Morales S; Carañana V; González A; Fernández-Morales LA; Moreno F; Casas MI; Angulo Mdel M; Cámara MC; Garcia-Mace AI; Carrasco E; Jara-Sánchez C
    Eur J Cancer; 2016 May; 58():122-9. PubMed ID: 26994459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Chemotherapy: Does It Only Provide False Hope? The Role of Palliative Care in a Young Patient With Newly Diagnosed Metastatic Adenocarcinoma.
    Doverspike L; Kurtz S; Selvaggi K
    J Adv Pract Oncol; 2017; 8(4):382-386. PubMed ID: 30018843
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Clemons M; Bouganim N; Smith S; Mazzarello S; Vandermeer L; Segal R; Dent S; Gertler S; Song X; Wheatley-Price P; Dranitsaris G
    JAMA Oncol; 2016 Feb; 2(2):225-31. PubMed ID: 26562292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow harvesting in outpatients.
    Thorne AC; Malbin KF; Jain M; Stewart M; Gulati SC
    J Clin Anesth; 1996 Nov; 8(7):551-6. PubMed ID: 8910176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach.
    Glück S; des Rochers C; Cano C; Dorreen M; Germond C; Gill K; Lopez P; Sinoff C
    Bone Marrow Transplant; 1997 Sep; 20(6):431-4. PubMed ID: 9313874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
    Fraschini G; Ciociola A; Esparza L; Templeton D; Holmes FA; Walters RS; Hortobagyi GN
    J Clin Oncol; 1991 Jul; 9(7):1268-74. PubMed ID: 1828499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in breast cancer patients before and after autologous bone marrow transplantation.
    McQuellon RP; Craven B; Russell GB; Hoffman S; Cruz JM; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Sep; 18(3):579-84. PubMed ID: 8879621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.
    Schwartzberg L; Morrow G; Balu S; Craver C; Gayle J; Cox D
    Curr Med Res Opin; 2011 Aug; 27(8):1613-22. PubMed ID: 21696263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.